Xgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?
XGEN PHARMS has eighteen approved drugs.
Drugs and US Patents for Xgen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xgen Pharms | LIOTHYRONINE SODIUM | liothyronine sodium | INJECTABLE;INJECTION | 076923-001 | Aug 17, 2005 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Xgen Pharms | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 065220-001 | Jul 28, 2006 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 211757-003 | Oct 18, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | IBUPROFEN LYSINE | ibuprofen lysine | INJECTABLE;INTRAVENOUS | 202402-001 | Mar 30, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 203999-001 | May 20, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 065013-001 | Aug 17, 2001 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | FOLIC ACID | folic acid | INJECTABLE;INJECTION | 202522-001 | Nov 6, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.